Table 4. Comparison of other clinical outcome parameters between sarcopenics and non-sarcopenics.
| Variable | Sarcopenic (n=76) (%) | Non-sarcopenic (n=35) (%) | P-value |
|---|---|---|---|
| Length of ICU stay (days) | 5 (2–28) | 5 (2–22) | 0.860 |
| Duration of MV (days) | 5.5 (1–28) | 5.5 (1–22) | 0.731 |
| Sepsis foci | |||
| Lung | 20 (50) | 5 (38.5) | 0.896 |
| SBP | 9 (22.5) | 2 (15.4) | |
| Blood culture | 5 (12.5) | 1 (7.7) | |
| Others | 6 (15) | 5 (38.5) | |
| New-onset infection | 27 (62.8) | 16 (37.2) | 0.306 |
| Incidence of feed intolerance during ICU stay | 22 (28.9) | 5 (14.3) | 0.094 |
| New-onset AKI | 7 (9.2) | 5 (14) | 0.546 |
| ICU mortality | 55 (72.4) | 14 (40) | 0.001* |
Data are expressed as median (min-max) or number (percentage),
*
significant at P<0.05; ICU: Intensive care unit; MV: Mechanical ventilation; SBP: Spontaneous bacterial peritonitis, AKI: Acute kidney injury